In sum, HA-ADT can suppress the proliferation, migration and invasion of human HCC cells via inhibition of the AKT/GSK-3β/β-catenin and TGF-β/Smad2/3 signaling pathways. This evidence concerns the gene AKT1 and hepatocellular carcinoma.